Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107
April 05, 2022 07:15 ET
|
Claritas Pharmaceuticals, Inc.
SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") today announced that...
Truveta announces new COVID-19 insights and unveils Truveta platform for the first time at #ViVE2022
March 08, 2022 12:04 ET
|
Truveta
Bellevue, WASH, March 08, 2022 (GLOBE NEWSWIRE) -- Truveta, the health system-led company with a vision of saving lives with data, unveiled the Truveta platform in its first public demonstration at...
Ananda Professional is Opening Enrollment to Participate in an IRB-Approved Phase IV Clinical Trial Investigating How CBD May Benefit Women's Health and Wellness
March 07, 2022 13:00 ET
|
Ananda Professional
GEORGETOWN, Ky., March 07, 2022 (GLOBE NEWSWIRE) -- Ananda Professional has committed $40 million to advance the clinical evidence of hemp extract through clinical research. As part of this...
Faro Health Inc. Expands Leadership Team and Announces Participation at SCOPE, Following Its $15 Million Series A Funding
February 03, 2022 05:00 ET
|
Faro Health Inc
LA JOLLA, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Faro Health, the clinical protocol solutions company, today announced that it has strengthened its leadership team with the appointment of...
Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study
November 30, 2021 08:50 ET
|
Love Pharma Inc.
NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its products to...
eSight Announces Clinical Research Partnership with Ocular Health Centre’s EyeStart Inc.
October 20, 2021 09:00 ET
|
eSight
TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight, today announces a new research and development partnership with the Ocular Health Centre, one of Ontario’s top...
RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia
September 27, 2021 06:00 ET
|
Rivanna Medical
CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial...
Aspero Medical announces patent award for their micro-texturing Pillar technology designed to improve outcomes of endoscopy procedures
August 17, 2021 10:46 ET
|
Innosphere Ventures
Boulder, Colorado, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup company developing new products for the field of gastroenterology, announced that the United States...
Multi-Center Study of SPRINT® PNS System for Chronic Low Back Pain Demonstrates Clinically Significant Improvements in Pain and Quality of Life
July 12, 2021 08:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from...
Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment
April 26, 2021 09:41 ET
|
SPR Therapeutics, Inc.
CLEVELAND, April 26, 2021 (GLOBE NEWSWIRE) -- Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists,...